SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Medicamen Organics Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

92885

INE0PE401018

23.677563

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MEDIORG

29.62

EPS(TTM)

Face Value()

Div & Yield %

Back

Eiko Lifesciences consolidated net profit rises 43.96% in the June 2026 quarter

Aug 12,2026

Net profit of Eiko Lifesciences rose 43.96% to Rs 1.31 crore in the quarter ended June 2026 as against Rs 0.91 crore during the previous quarter ended June 2025. Sales rose 56.40% to Rs 16.75 crore in the quarter ended June 2026 as against Rs 10.71 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	16.75	10.71	56
OPM %	11.52	14.10	-
PBDT	2.25	1.73	30
PBT	2.00	1.47	36
NP	1.31	0.91	44

78,009.25 -70.71 ( -0.09%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)